Pharmaceuticals

Metronidazole Market Revenue Projected To Hit $41.22 Billion By 2030 With 40.6% CAGR

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Metronidazole Market Over The 2026–2030 Period?

The metronidazole market size has demonstrated significant expansion in recent years. It is projected to increase from $0.61 billion in 2025 to $0.65 billion in 2026, at a compound annual growth rate (CAGR) of 5.5%. This historical growth can be ascribed to factors such as a high occurrence of bacterial and protozoal infections, its enduring clinical efficacy, widespread inclusion in essential medicines lists, increased hospital antibiotic utilization, and a rise in surgical procedures.

The metronidazole market size is anticipated to experience robust expansion over the coming years. This market is projected to reach $0.8 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth during the projected period include a rising global infection burden, increasing hospital admissions, sustained demand for affordable antibiotics, expansion of outpatient antimicrobial therapy, and growth in emerging healthcare markets. Key trends expected within the forecast timeframe involve widespread use in anaerobic bacterial infections, growing demand for broad-spectrum antimicrobials, expansion of topical and oral formulations, increased use in gynecological and gastrointestinal infections, and a rising preference for cost-effective generic antibiotics.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21222&type=smp

What Key Factors Are Shaping The Metronidazole Market Landscape?

The metronidazole market is projected to expand due to the rising occurrence of bacterial infections. These diseases are characterized by the multiplication and spread of harmful bacteria within the body. The escalation in bacterial infection cases is influenced by factors such as antibiotic resistance, environmental shifts, and an expanding immunocompromised population. Metronidazole functions by damaging bacterial DNA, which stops their reproduction and dissemination, making it effective against anaerobic bacteria and specific protozoal infections by inhibiting their growth and treating the condition. As an illustration, in November 2025, the UK Health Security Agency, a UK government agency, indicated that cases of antibiotic-resistant bacteraemia—a severe infection where bacteria enter the bloodstream—have climbed by 9.3% since 2023, moving from 18,740 cases in 2023 to 20,484 in 2024. Consequently, the increasing incidence of bacterial infections is set to fuel the growth of the metronidazole market.

What Are The Different Segment Types In The Metronidazole Market Segment Breakdown?

The metronidazole market covered in this report is segmented –

1) By Formulation Type: Tablets, Capsules, Intravenous (IV) Solutions, Topical Creams Or Ointments, Other Formulation Types

2) By Application: Bacterial Infections, Parasitic Infections, Gynecological Infections, Surgical Prophylaxis, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

4) By End-User: Hospitals, Clinics, Homecare, Other End Users

Subsegments:

1) By Tablets: Immediate Release Tablets, Extended Release Tablets

2) By Capsules: Immediate Release Capsules, Extended Release Capsules

3) By Intravenous (IV) Solutions: Single-dose IV Solutions, Multi-dose IV Solutions

4) By Topical Creams Or Ointments: Topical Creams, Topical Ointments

5) By Other Formulation Types: Oral Suspension, Vaginal Gels Or Suppositories

Which Trends Are Impacting The Progress Of The Metronidazole Market?

Leading companies active in the metronidazole market are concentrating on developing advanced offerings, such as pre-prepared oral liquids. This focus aims to boost patient adherence, particularly for individuals who find swallowing tablets difficult or require simpler administration for infection treatment. These ready-to-use oral liquids are liquid medications that arrive pre-formulated, eliminating the need for further preparation or mixing before consumption, which provides convenience for patients. For instance, in November 2023, Kesin Pharma Corporation, a US-based specialty pharmaceutical company, announced that the Food and Drug Administration (FDA) approved LIKMEZ (metronidazole) oral suspension, 500 mg/5 mL. This is an innovative version of a widely used antibiotic drug, specifically designed to improve patient compliance, and it is approved for treating trichomoniasis and anaerobic bacterial infections in adults, as well as amebiasis in adults and children. LIKMEZ is offered as a strawberry peppermint-flavored suspension in a 200 mL bottle, featuring a 24-month shelf life and not requiring refrigeration.

Who Are The Well-Known Companies In The Metronidazole Market?

Major companies operating in the metronidazole market are Pfizer Inc., Merck & Co. Inc., Abbott Laboratories, Fresenius Kabi AG, Baxter International Inc., Sandoz Group AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., Lupin Pharmaceuticals Inc., Zydus Lifesciences, YiChang HEC ChangJiang Pharmaceutical Co. Ltd., Aarti Drugs Ltd., Unichem Laboratories, Cosette Pharmaceuticals Inc., Saptalis Pharmaceuticals LLC, Huanggang Saikang Pharmaceutical Co. Ltd., Kesin Pharma, Hubei Hongyuan Pharmaceutical Technology Co. Ltd., Huanggang Yinhe Aarti Pharmaceutical Co. Ltd., Higgs Healthcare

Get The Full Metronidazole Market Report:

https://www.thebusinessresearchcompany.com/report/metronidazole-global-market-report

Which Region Is The Leading Market For The Metronidazole Market?

Asia-Pacific was the largest region in the metronidazole market in 2025. The regions covered in the metronidazole market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Metronidazole Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/metronidazole-global-market-report

Browse Through More Reports Similar to the Global Metronidazole Market 2026, By The Business Research Company

Microalgae Market Report 2026

https://www.thebusinessresearchcompany.com/report/microalgae-global-market-report

Cytotoxic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/cytotoxic-drugs-global-market-report

Tofacitinib Market Report 2026

https://www.thebusinessresearchcompany.com/report/tofacitinib-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795